Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Nicotrol Articles

IVAX to acquire inhalation delivery system company

2 June 2003

Consolidation, restructuring within the OTC sector "is coming soon"

2 May 2000

P&U's Nicotrol Inhaler Launched In USA

19 May 1997

P&U's Nicotrol Inhaler Approvable In USA

23 December 1996

J&J's Nicotrol Approved

15 July 1996

P&U Seeks Approval For Inhaled Nicotine

10 June 1996

Nicotine Replacement Goes OTC In The USA

29 April 1996

US FDA Approves McNeil's Nicotrol NS

1 April 1996

New Pharma Facility For Ciba

5 December 1994

McNeil To Market Nicotine Nasal Spray

21 November 1994

CYGNUS TO FILE FOR ALPRAZOLAM PATCH

23 August 1993

NICOTROL APPROVAL IN CANADA

26 July 1993

JOUVEINAL PRODUCTS EFFECT ON W-L PIPELINE

8 February 1993

US RESULTS 3RD QTR

2 November 1992

WARNER-LAMBERT EARNINGS FORECAST

29 June 1992

3rd QTR LAUNCH IN USA FOR NICOTROL

11 May 1992

WARNER-LAMBERT'S NICOTROL

4 May 1992

WARNER-LAMBERT'S VIEW TO THE FUTURE

27 April 1992

Showing 1-18 of 18 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS